TY - JOUR
T1 - A new XRCC1-containing complex and its role in cellular survival of methyl methanesulfonate treatment
AU - Luo, Hao
AU - Chan, Doug W.
AU - Yang, Tao
AU - Rodriguez, Maria
AU - Chen, Benjamin Ping Chi
AU - Leng, Mei
AU - Mu, Jung Jung
AU - Chen, David
AU - Songyang, Zhou
AU - Wang, Yi
AU - Qin, Jun
PY - 2004/10
Y1 - 2004/10
N2 - DNA single-strand break repair (SSBR) is important for maintaining genome stability and homeostasis. The current SSBR model derived from an in vitro-reconstituted reaction suggests that the SSBR complex mediated by X-ray repair cross-complementing protein 1 (XRCC1) is assembled sequentially at the site of damage. In this study, we provide biochemical data to demonstrate that two preformed XRCC1 protein complexes exist in cycling HeLa cells. One complex contains known enzymes that are important for SSBR, including DNA ligase 3 (DNL3), polynucleotide kinase 3′-phosphatase, and polymerase β; the other is a new complex that contains DNL3 and the ataxia with oculomotor apraxia type 1 (AOA) gene product aprataxin. We report the characterization of the new XRCC1 complex. XRCC1 is phosphorylated in vivo and in vitro by CK2, and CK2 phosphorylation of XRCC1 on S518, T519, and T523 largely determines aprataxin binding to XRCC1 though its FHA domain. An acute loss of aprataxin by small interfering RNA renders HeLa cells sensitive to methyl methanesulfonate treatment by a mechanism of shortened half-life of XRCC1. Thus, aprataxin plays a role to maintain the steady-state protein level of XRCC1. Collectively, these data provide insights into the SSBR molecular machinery in the cell and point to the involvement of aprataxin in SSBR, thus linking SSBR to the neurological disease AOA.
AB - DNA single-strand break repair (SSBR) is important for maintaining genome stability and homeostasis. The current SSBR model derived from an in vitro-reconstituted reaction suggests that the SSBR complex mediated by X-ray repair cross-complementing protein 1 (XRCC1) is assembled sequentially at the site of damage. In this study, we provide biochemical data to demonstrate that two preformed XRCC1 protein complexes exist in cycling HeLa cells. One complex contains known enzymes that are important for SSBR, including DNA ligase 3 (DNL3), polynucleotide kinase 3′-phosphatase, and polymerase β; the other is a new complex that contains DNL3 and the ataxia with oculomotor apraxia type 1 (AOA) gene product aprataxin. We report the characterization of the new XRCC1 complex. XRCC1 is phosphorylated in vivo and in vitro by CK2, and CK2 phosphorylation of XRCC1 on S518, T519, and T523 largely determines aprataxin binding to XRCC1 though its FHA domain. An acute loss of aprataxin by small interfering RNA renders HeLa cells sensitive to methyl methanesulfonate treatment by a mechanism of shortened half-life of XRCC1. Thus, aprataxin plays a role to maintain the steady-state protein level of XRCC1. Collectively, these data provide insights into the SSBR molecular machinery in the cell and point to the involvement of aprataxin in SSBR, thus linking SSBR to the neurological disease AOA.
UR - http://www.scopus.com/inward/record.url?scp=4544314723&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=4544314723&partnerID=8YFLogxK
U2 - 10.1128/MCB.24.19.8356-8365.2004
DO - 10.1128/MCB.24.19.8356-8365.2004
M3 - Article
C2 - 15367657
AN - SCOPUS:4544314723
SN - 0270-7306
VL - 24
SP - 8356
EP - 8365
JO - Molecular and cellular biology
JF - Molecular and cellular biology
IS - 19
ER -